Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
Appointed director
Inv. presentation
Appointed CFO
|
|
PDL BIOPHARMA, INC. (PDLI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/24/2019 |
8-K
| Appointed a new director|
Docs:
|
"Offer Letter between the Company and Ed Imbrogno",
"Natasha A. Hernday Elected to PDL BioPharma’s Board of Directors INCLINE VILLAGE, Nev. - PDL BioPharma, Inc. announces that at its 2019 annual meeting of stockholders held June 20, 2019, the Company's stockholders elected Natasha A. Hernday to the Company's Board of Directors. This appointment increases PDL’s Board membership to nine, including seven independent Directors. The Company also announced that its stockholders voted to re-elect Harold E. Selick, Ph.D. and Samuel R. Saks, M.D. as Directors, and approved, on an advisory basis, executive officer compensation. Ms. Hernday brings to PDL approximately 25 years of biotechnology experience and currently serves as Senior Vice President, Corporate Development and a member of the Executive Committee of Seattle Genetics, Inc. . “Natasha is..." |
|
| 05/22/2013 |
8-K
| Appointed a new director |
|
|